U.S. Army Captain Michael Kelvington, commander of the Battle company, 1-508 Parachute Infantry battalion, 4th Brigade Combat Team, 82nd Airborne Division, bows next to remains of Gulam Dostager, a member of Afghan Local Police who was killed in the blast of an Improvised Explosive Device (IED) during the joint Tor Janda (Black Flag in Pashtu) operation, in Zahri district of Kandahar province, southern Afghanistan May 25, 2012.  REUTERS/Shamil Zhumatov  (AFGHANISTAN - Tags: MILITARY CIVIL UNREST CONFLICT TPX IMAGES OF THE DAY)

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz (UNITED STATES - Tags: MILITARY ANNIVERSARY TPX IMAGES OF THE DAY)

Fleet Week

The U.S. Navy takes Manhattan for a week.  Slideshow 

Photo

The SpaceX mission

A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station.  Slideshow 

Researchers take another stem cell step

Related Topics

An ampoule containing a medium for stem cell storage is displayed in front of a microscopic photograph showing a human embryonic stem cell at the UK Stem Cell Bank in north London, May 19, 2004. REUTERS/Peter MacDiarmid

An ampoule containing a medium for stem cell storage is displayed in front of a microscopic photograph showing a human embryonic stem cell at the UK Stem Cell Bank in north London, May 19, 2004.

Credit: Reuters/Peter MacDiarmid

WASHINGTON | Fri Oct 9, 2009 11:34am EDT

WASHINGTON (Reuters) - Researchers trying to figure out a safe way to turn an ordinary skin cell into a powerful stem cell treatment said they took another big step on Thursday, using one chemical to partly transform the cells.

Dr. Kevin Eggan of the Harvard Stem Cell Institute and colleagues said their experiment makes it easier to change plain cells into what they called induced pluripotent stem or iPS cells, which have the power to morph into any cell type in the body.

"This demonstrates that we're halfway home, and remarkably we got halfway home with just one chemical," Eggan said in a statement.

The goal is to take a small skin sample or blood from a patient, reprogram the cells into iPS cells, grow a large batch of these and then use them to make heart cells, blood cells, nerve cells or perhaps someday even entire organs to treat disease.

They would be tailor-made for the patient, who would not require immune-suppressing drugs. Such cells can also be used to study a patient's disease in the laboratory.

Stem cells are the body's master cells, giving rise to all the other cells in the body. Days after conception, an embryo is made of incredibly powerful stem cells that can develop into any cell type.

As an embryo grows and develops, these cells differentiate and lose their flexibility as they become muscle cells, bone cells or nerve cells.

Scientists seeking to recapture this power can use human embryos. An alternative route is to make iPS cells, but the most reliable method to do this requires using viruses to carry transformative genes into the cells.

The worry is the viruses might contaminate the resulting batches of cells.

Eggan's team found a chemical that replaces two of the four transformative genes known as cMyc, Sox2, Oct4, and Klf4.

"The one chemical replaces those two genes in different ways at different times in the experiment. The experiments we performed not only led to discovery of the chemical, but they also explained how it works," he said.

They have named the chemical RepSox -- in honor of Boston's Red Sox baseball team and a play on the name of one of the genes.

(Editing by Vicki Allen)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.